Patents by Inventor Sajjad A. Qureshi

Sajjad A. Qureshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating diabetes and related conditions
    Publication number: 20060035958
    Abstract: The present invention addresses the use of substituted thiophene derivatives, as well as compositions containing such compounds for treating type 2 diabetes mellitus. The compounds in the present invention are glucagon antagonists. The compounds block the action of glucagon at its receptor and thereby decrease the levels of plasma glucose providing a treatment of diabetes.
    Type: Application
    Filed: September 8, 2003
    Publication date: February 16, 2006
    Inventors: Joseph Duffy, Elizabeth Campbell, Sajjad Qureshi, Bei Zhang, James Tata, Zenon Konteatis, Rui Liang
  • Cyanothiophene derivatives, compositions containing such compounds and methods of use
    Publication number: 20040097557
    Abstract: The present invention addresses substituted cyanothiophene derivatives of the formula I: 1
    Type: Application
    Filed: November 12, 2003
    Publication date: May 20, 2004
    Inventors: Joseph L. Duffy, Rui Liang, Elizabeth Louise Campbell, Sajjad A. Qureshi, Bei B. Zhang, James R. Tata, Brian A. Kirk, Kevin T. Chapman, Zenon Konteatis
  • Leptin assay
    Patent number: 6007998
    Abstract: A trans-activation assay for leptin is described. Leptin response elements are located proximal to a promoter, and the promoter region is operatively linked to a reporter gene. When leptin binds with the receptor, the reporter gene is transcribed.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: December 28, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Charles I. Rosenblum, Leonardus H. T. Van Der Ploeg, Sajjad A. Qureshi, Doris F. Cully, John W. Hess, Michael R. Tota, Fang Chen